Association of the aromatase gene (Cyp19) and endometrial cancer - Testing for Hardy-Weinberg disequilibrium in cancer patients.

被引：0
|
作者：
Gu, CC
Mutch, DG
Goodfellow, PJ
机构：
[1] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2000年 / 67卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
468
引用
收藏
页码：97 / 97
页数：1
相关论文
共 50 条
  • [21] A haplotype analysis of CYP19 (aromatase) and genetic predisposition to ovarian cancer
    Levine, Douglas A.
    Lee, Catherine S.
    Bogomolniy, Faina
    Boyd, Jeff
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : S22 - S22
  • [22] A common SNP of the human CYP4Z1 gene showing female-specific Hardy-Weinberg disequilibrium
    Roos, P. H.
    Weistenhofer, W.
    Golka, K.
    Lohlein, D.
    Tschirbs, S.
    Kohler, C. U.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 99 - 99
  • [23] Association of Cyp19 (aromatase) and SHBG gene polymorphisms with plasma hormone levels in postmenopausal women: implications for breast cancer.
    Dowsett, M
    Dunning, AM
    Healey, CS
    Tee, L
    Folkerd, E
    Easton, DF
    Luben, RN
    Day, NE
    Ponder, BAJ
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S154 - S154
  • [24] Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk
    Healey, CS
    Dunning, AM
    Durocher, F
    Teare, D
    Pharoah, PDP
    Luben, RN
    Easton, DF
    Ponder, BAJ
    CARCINOGENESIS, 2000, 21 (02) : 189 - 193
  • [25] ASSOCIATION OF AROMATASE (CYP19) GENE POLYMORPHISMS WITH ESTRADIOL AND ESTRONE LEVELS IN POSTMENOPAUSAL WOMEN
    Schuit, S. C. E.
    Uitterlinden, A. G.
    Kock, N. W. N.
    Stolk, L.
    Van Meurs, J. B. J.
    Schoofs, M. W. C. J.
    Zillikens, C. M. C.
    Hofman, A.
    Van Leeuwen, J. P. T. M.
    Pols, H. A. P.
    De Jong, F. H.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S43 - S43
  • [26] A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk
    Talbott, Kathryn E.
    Gammon, Marilie D.
    Kibriya, Muhammad G.
    Chen, Yu
    Teitelbaum, Susan L.
    Long, Chang-Min
    Gurvich, Irina
    Santella, Regina M.
    Ahsan, Habibul
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 111 (03) : 481 - 487
  • [27] Changes in aromatase (CYP19) gene promoter usage in non-small cell lung cancer
    Demura, Masashi
    Demura, Yoshiki
    Ameshima, Shingo
    Ishizaki, Takeshi
    Sasaki, Masato
    Miyamori, Isamu
    Yamagishi, Masakazu
    Takeda, Yoshiyu
    Bulun, Serdar E.
    LUNG CANCER, 2011, 73 (03) : 289 - 293
  • [28] A rare CYP19 (aromatase) variant may increase the risk of breast cancer
    Kristensen, VN
    Andersen, TI
    Lindblom, A
    Erikstein, B
    Magnus, P
    Borresen-Dale, AL
    PHARMACOGENETICS, 1998, 8 (01): : 43 - 48
  • [29] A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk
    Kathryn E. Talbott
    Marilie D. Gammon
    Muhammad G. Kibriya
    Yu Chen
    Susan L. Teitelbaum
    Chang-Min Long
    Irina Gurvich
    Regina M. Santella
    Habibul Ahsan
    Breast Cancer Research and Treatment, 2008, 111 : 481 - 487
  • [30] Association of the polymorphisms CYP19 (TTTA)n in treatment response to hormone therapy based in aromatase inhibitors in breast cancer patients
    Murillo-Ortiz, B.
    Castillo-Valenzuela, R. dC.
    Martinez-Garza, S.
    Moreno-Perez, A.
    Silva, A.
    Ruiz-Garcia, E.
    Astudillo-de la Vega, H.
    CANCER RESEARCH, 2009, 69 (02) : 215S - 215S
12345